Elaine Chen is a graduate student in the department of Pathology, Microbiology, and Immunology at Vanderbilt, mentored by Dr. James E. Crowe, Jr. She obtained her B.S. in Biomedical Sciences from Texas A&M University - College Station in December 2017, and conducted research on engineering DARPin inhibitors of C.diff Toxin B. Upon graduation, Elaine worked at Biodesix on their assay development team as well as at Lilly Biotechnology Center on their Protein Biosciences team. Elaine entered Vanderbilt as part of the Interdisciplinary Graduate Program (IGP) in 2018, and subsequently joined the Crowe Lab in 2019. Currently her research involves using next generation sequencing of B cells to answer questions on different infections/disease states.